Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...

Washington researchers and care providers are struggling to keep up with new chemicals in the region’s illicit drug supply.

The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...

A consortium including scientists from the Tropical Institute at LMU University Hospital has demonstrated the effectiveness of a new antibiotic.

Tuberculosis (TB) is the world's biggest infectious disease killer, with multidrug-resistant TB (MDR-TB) posing a particular ...

A review of the FDA’s drug approvals of 2024 shows that small companies loomed large—both in the sheer number of nods g | ...

Tuberculosis (TB) is the world's biggest infectious disease killer with multidrug-resistant TB (MDR-TB) posing a particular threat to global health. A study shows that resistance to the new MDR-TB ...

Chicago-based Meitheal Pharmaceuticals, along with its Chinese parent, was busy in 2024, adding both biosimilar drugs and ...

Researchers at McMaster University have discovered a critical vulnerability in drug-resistant bacteria: zinc -- or a lack thereof. In a recent study, published in the journal Nature Microbiology, ...

Carbapenems are last-resort antibiotics for treating bacterial infections. A study shows how zinc plays a role in drug-resistant bacteria.

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...